WO2021085565A1 - マルチショット注射パッチ - Google Patents
マルチショット注射パッチ Download PDFInfo
- Publication number
- WO2021085565A1 WO2021085565A1 PCT/JP2020/040706 JP2020040706W WO2021085565A1 WO 2021085565 A1 WO2021085565 A1 WO 2021085565A1 JP 2020040706 W JP2020040706 W JP 2020040706W WO 2021085565 A1 WO2021085565 A1 WO 2021085565A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- container
- charge
- shot injection
- fire
- base
- Prior art date
Links
- 238000002347 injection Methods 0.000 title claims abstract description 121
- 239000007924 injection Substances 0.000 title claims abstract description 121
- 239000003814 drug Substances 0.000 claims abstract description 53
- 229940079593 drug Drugs 0.000 claims abstract description 52
- 239000010410 layer Substances 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 25
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 230000004888 barrier function Effects 0.000 claims description 6
- 239000012790 adhesive layer Substances 0.000 claims description 5
- 239000000243 solution Substances 0.000 description 56
- 239000003795 chemical substances by application Substances 0.000 description 31
- 230000008901 benefit Effects 0.000 description 9
- 238000003466 welding Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 7
- 239000000945 filler Substances 0.000 description 6
- 239000002360 explosive Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000002485 combustion reaction Methods 0.000 description 4
- 230000037368 penetrate the skin Effects 0.000 description 4
- 238000004891 communication Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- AXZAYXJCENRGIM-UHFFFAOYSA-J dipotassium;tetrabromoplatinum(2-) Chemical compound [K+].[K+].[Br-].[Br-].[Br-].[Br-].[Pt+2] AXZAYXJCENRGIM-UHFFFAOYSA-J 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 229910001487 potassium perchlorate Inorganic materials 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 229910052726 zirconium Inorganic materials 0.000 description 2
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000005474 detonation Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000003721 gunpowder Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000001141 propulsive effect Effects 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/1407—Infusion of two or more substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/14586—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of a flexible diaphragm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8206—Internal energy supply devices battery-operated
Definitions
- the present disclosure relates to devices and methods for needleless injection of drugs. More specifically, the device and method relate to a wearable device that provides multiple needleless injections of a drug through the patient's skin.
- a needleless injection system is known.
- the driving force adopted by these systems includes pyrotechnics, springs, electromagnetic actuators and the like (see, eg, Patent Document 1).
- the devices in these systems are of single-shot design and are not suitable as wearable devices due to their considerable length.
- Certain embodiments of the invention provide multiple needleless injection devices mounted on a single wearable patch. For example, a doctor may require a patient to receive an injection of a drug every 3 hours for 3 days. Currently, if the patient is unable to inject himself, or if the type of injection is not suitable for the patient to self-administer, then medical professionals need to visit the patient frequently, or even If not, the patient may need to visit the health clinic frequently or be hospitalized while the patient is being treated. Embodiments of the invention allow the patient to automatically make the necessary injections while wearing the device of the invention and perhaps performing normal daily activities.
- each injection device is actuated by an electric current that ignites the fire charge in the injection device.
- electronic devices are employed to control the operation or ignition of each injection device.
- the electronic device can independently operate or ignite each injection device.
- the patch is compact and thin enough to be worn by the patient, so that the injections can be administered remotely or in a given time series.
- the patch is about 5 mm to 10 mm thick. In certain embodiments, the patch is suitable as a wearable device. In certain embodiments, each injecting device having a diameter of about 5 mm to 10 mm, several injecting devices can be placed on the same wearable patch.
- the wearable multi-shot injection patch can include a base having a bottom and a top surface.
- the bottom surface is configured to be positioned relative to the patient's skin.
- the patch further comprises a first container (receptacle) that is supported by the base and contains the first drug, and a second container that is supported by the base and contains the second drug.
- the first fire charge is placed in the base between the top surface and the first container.
- the second fire charge is placed in the base between the top surface and the second container.
- One or more electronic components are configured to detonate (ignite, trigger) a first fire charge and a second fire charge.
- the first nozzle is supported by the base and is located on the opposite side of the first container with respect to the first igneous charge.
- the second nozzle is supported by the base and is located on the opposite side of the second container with respect to the second igneous charge.
- the wearable multi-shot injection patch can include a base having a bottom and a top surface.
- the bottom surface is configured to be positioned relative to the patient's skin.
- Two or more containers are supported by the base and contain a solution containing one or more agents and other components.
- the two or more vessels release the solution simultaneously or continuously by using a fire engineer ignited by an electric pulse to allow the solution to penetrate (penetrate) the patient's skin.
- the wearable injection patch can include a base having a bottom and a top surface.
- the bottom surface is configured to be positioned relative to the patient's skin.
- the container is formed by an outer wall and contains the drug.
- the outer wall is supported by the base. The fire charge is placed between the container and the outer wall in the base.
- the method for producing a wearable multi-shot injection patch is a first component having a bottom surface and a top surface and comprising a plurality of containers disposed between the bottom surface and the top surface. It can include providing a subassembly. The bottom surface is configured to be positioned relative to the patient's skin. Each container in a plurality of containers contains a drug. This method continues by providing a second component assembly that includes multiple chambers. Each chamber in the plurality of chambers contains a fire charge. This method is continued by joining the second component assembly to the top surface of the first component assembly so that the plurality of chambers are located on opposite sides of the plurality of containers as viewed from the bottom surface.
- a method for injecting a drug through a patient's skin with a wearable patch having a bottom and a top surface comprises a plurality of containers and a plurality of chambers aligned with the plurality of containers.
- Multiple containers are placed between the bottom surface and the top surface, each container holds the drug, each of the plurality of chambers is placed between the plurality of containers and the top surface, and each chamber holds the fire charge.
- the container can be compressed to at least eject the drug from the container through the patient's skin.
- the wearable multi-shot injection patch is supported by and supported by a base that has a bottom and a top surface and is configured such that the bottom surface is located with respect to the patient's skin.
- an injection patch that can be worn for needleless injection of a drug through the skin of a patient.
- FIG. 1 is a perspective view of an embodiment of a patch comprising a plurality of injection devices distributed across the patch according to a preferred embodiment of the present invention.
- FIG. 2 is a top view of the patch of FIG. 1 showing one or more electronic components for detonating a plurality of igneous charges for a plurality of injection devices.
- FIG. 3 is a perspective exploded view of the patch of FIG. 1, showing two or more containers, a mask layer, and a plurality of igneous charges that contain solutions aligned below the clamp sheet and above the sheet. ..
- FIG. 4 is a cross-sectional view of the patch of FIG. 2 as viewed along the cut plane 4-4 of FIG.
- FIG. 5 is a cross-sectional view similar to FIG. 4 except that the release liner has been removed and one of the plurality of fireworks charges has been detonated to eject the solution from its nozzle into the patient's skin.
- FIG. 6 is a perspective exploded view of a first component assembly of a patch that includes one or more electronic components, a plurality of fireworks charges, a mask layer, and a sheet.
- FIG. 7A is a cross-sectional view of the first component assembly of FIG. 6 as viewed along the cut surfaces 7A-7A of FIG. The circuit board which supports one is shown.
- FIG. 7B is a cross-sectional view similar to FIG. 7A, except that the circuit board is assembled on the lower surface of the mask layer and the sheet is assembled on the upper surface of the mask layer.
- FIG. 8 is a perspective exploded view of a second component assembly of a patch that includes a clamp sheet and two or more containers. Two or more containers are aligned with the recesses of the clamp sheet. The removable release liner is shown placed above the clamp sheet.
- 9A is a cross-sectional view of the second component assembly of FIG. 8 as viewed along the cut surfaces 9A-9A of FIG.
- FIG. 10 shows another embodiment of the container of FIG. 4 having a truncated triangular shape.
- FIG. 11 shows another embodiment of the container of FIG. 4 having a truncated pentagonal shape.
- FIG. 1 is a perspective view of an embodiment of patch 10 comprising a plurality of injection (injection) devices 11 (see FIG. 5) distributed over patch 10 according to a preferred embodiment of the present invention.
- the patch 10 comprises a base 12 having a bottom surface 14 and a top surface 16.
- the bottom surface 14 is configured to be positioned relative to the patient's skin 13, as best shown in FIG.
- patch 10 comprises two or more containers 18 (a)-(i). In certain embodiments, two or more containers 18 (a)-(i) are supported by the base 12. In certain embodiments, two or more containers 18 (a)-(i) contain the drug. In certain embodiments, the agent is solution 44. In certain embodiments, solution 44 comprises one or more agents and other ingredients. In a particular embodiment, the agent or solution 44 in two or more containers 18 (a)-(i) is the same. In certain embodiments, the agents or solutions 44 in two or more containers 18 (a)-(i) are different. In certain embodiments, the agents or solutions 44 in two or more containers 18 (a)-(i) are different but complementary to each other.
- each of the two or more containers 18 (a)-(i) comprises a flexible spherical container for receiving the solution 44.
- solution 44 is received by injecting solution 44 into two or more containers 18 (a)-(i).
- the solution 44 is injected into two or more containers 18 (a)-(i) prior to assembling the patch 10.
- solution 44 is injected into two or more containers 18 (a)-(i) during patch 10 assembly.
- the solution 44 is injected into two or more containers 18 (a)-(i) after the patch 10 is assembled.
- patch 10 comprises a plurality of explosives (explosives) 20 (a)-(i).
- the plurality of fire charge 20 (a)-(i) are supported by the base 12.
- the plurality of fire engine charges 20 (a) to (i) can be provided with any suitable ignition material.
- each of the plurality of fire charge 20 (a)-(i) comprises a mixture of zirconium and potassium perchlorate.
- the mixture further comprises a binder.
- a plurality of fire charge 20 (a)-(i) are deposited as a wet slurry and then dried.
- the plurality of fireworks charges 20 (a) to (i) are configured to release the solution 44 from two or more containers 18 (a) to (i) in a controlled manner.
- the two or more containers 18 (a)-(i) are preferably associated with each of the two or more containers 18 (a)-(i) where the combustion and expansion of the fire engine charge 20 is associated.
- Has sufficient flexibility (flexibility) so that the container can be sufficiently deformed to eject (drain) the solution 44 or the drug through one or more nozzles 26 (a)-(i). doing.
- the solution 44 preferably penetrates the patient's skin 13.
- the plurality of fire charge 20 (a)-(i) simultaneously releases the solution 44 from the plurality (two or more) containers 18 (a)-(i). In a particular embodiment, the plurality of fire charge 20 (a)-(i) continuously (sequentially) release the solution 44 from the plurality (two or more) containers 18 (a)-(i). ..
- the desired depth is predetermined.
- the desired depth is determined at least in part based on the composition of the released agent or solution 44. For example, the desired depth can be set to a different depth for each injection device 11 on the same patch 10.
- patch 10 comprises one or more electronic components 22 for detonating (igniting) a plurality of fire engine charges 20 (a)-(i).
- one or more electronic components 22 are supported by a base 12.
- the one or more electronic components 22 are configured to generate an electric current for detonating the plurality of fireworks charges 20 (a)-(i). In certain embodiments, the one or more electronic components 22 are configured to selectively detonate a plurality of fire engine charges 20 (a)-(i). In a particular embodiment, the one or more electronic components 22 are configured to independently detonate each of the plurality of fire engine charges 20 (a)-(i). In a particular embodiment, the one or more electronic components 22 are configured to simultaneously detonate two or more of the plurality of fire engine charges 20 (a)-(i).
- one or more electronic components 22 are configured to be remotely controlled. In certain embodiments, the one or more electronic components 22 are configured to be controlled in a predetermined time series.
- one or more electronic components 22 include a controller.
- the controller is a microcontroller.
- the controller is programmable.
- one or more electronic components 22 are programmed for the required number of injections, injection interval, and suitable containers 18 (a)-(i) for containing the desired drug or solution 44. There is.
- patch 10 once patch 10 is applied to the patient's skin 13, patch 10 automatically administers the drug without intervention from a healthcare professional.
- the controller is configured to store an instruction to detonate at least one of a plurality of fire charge 20 (a)-(i).
- the instructions specify the detonation intervals for the plurality of fireworks charges 20 (a)-(i).
- one or more electronic components 22 include a timer. In such an embodiment, the controller can be configured to detonate at least one of the plurality of fire charge 20 (a)-(i) based at least in part on a timer.
- one or more electronic components 22 include a receiver configured to receive a radio signal.
- the one or more electronic components 22 are intended to detonate at least one of the plurality of fire engine charges 20 (a)-(i) based at least in part on the radio signal.
- the receiver is configured to receive a radio signal from the patient.
- the receiver is configured to receive a radio signal from a medical professional.
- patch 10 is configured such that the patient activates one or more electronic components 22 to detonate at least one of the plurality of fire engine charges 20 (a)-(i). It has a patched user interface.
- patch 10 comprises an energy source for one or more electronic components 22.
- the energy source is supported by the base 12.
- the energy source may be the battery 24.
- the battery 24 powers one or more electronic components 22 to fire the selected injection device 11.
- the one or more electronic components 22 are first selected in one or more of the plurality of fire engine charges 20 (a)-(i) during the first time frame. An electrical pulse is supplied, and then a second electric pulse is supplied to another selected one or more of the plurality of fire charge 20 (a) to (i) during the second time frame.
- FIG. 2 is a plan view of the patch 10 of FIG. 1, which comprises one or more electronic components 22 for detonating a plurality of fire engine charges 20 (a)-(i) for the plurality of injection devices 11. Shown.
- the patch 10 comprises nine injection devices 11 arranged in a grid pattern.
- the patch 10 can include only two injection devices 11.
- the patch 10 comprises more than nine injection devices 11.
- the two or more containers 18 (a) to (i) have the same size.
- at least one container 18 (a)-(i) has a different size than another container 18 (a)-(i).
- size is a measure of the outer diameter of containers 18 (a)-(i).
- size is a measure of the inner diameter of containers 18 (a)-(i).
- size is a measure of the volume of containers 18 (a)-(i).
- the volumes of containers 18 (a)-(i) are selected at least in part based on the drug or solution 44 contained in containers 18 (a)-(i).
- the first agent may require a larger dose because it is more effective than the second agent.
- a single patch 10 can include containers 18 (a)-(i) with different volumes.
- the patch 10 comprises containers 18 (a)-(i) of similar size and the dose (dose) needs to be resized (changed), one or more electronic components 22. Can detonate two or more of a plurality of fireworks charges 20 (a) to (i) to increase the size of a single dose (dose).
- the injection device 11 can be arranged in a symmetrical or asymmetric pattern over the base 12 of the patch 10.
- the injection device 11 is arranged across the base 12 of the patch 10 in a square pattern, a circular pattern, or any other spatial arrangement.
- clusters of injection devices 11 are arranged over the base 12 of patch 10.
- the injection devices 11 within a single cluster are grouped in a linear fashion.
- the injection devices 11 within a single cluster are grouped in close proximity at a single location (eg, a circle) in patch 10.
- one or more electronic components 22 including the battery 24 are arranged on the outer periphery of the patch 10.
- one or more electronic components 22 are embedded in the base 12 between the injection devices 11.
- one or more electronic components 22 are placed on the top surface 16 of the patch 10.
- one or more electronic components 22 are placed on the sides of the base 12.
- each of the two or more containers 18 (a)-(i) comprises one of the nozzles 26 (a)-(i).
- the nozzles 26 (a)-(i) are supported by the base 12.
- the nozzles 26 (a)-(i) are located on opposite sides of the two or more containers 18 (a)-(i) as viewed from the plurality of fireworks charge 20 (a)-(i). Will be done.
- the nozzles 26 (a)-(i) are arranged in a grid pattern across the patch 10.
- each nozzle 26 (a) to (i) is aligned with one of the containers 18 (a) to (i).
- each nozzle 26 (a)-(i) is in fluid communication with one of two or more containers 18 (a)-(i).
- the two or more nozzles 26 (a)-(i) are in fluid communication with one of the two or more containers 18 (a)-(i).
- each nozzle 26 (a)-(i) is in fluid communication with two or more containers 18 (a)-(i).
- the fire engine charge 20 for the first injection device 11 ejects the drug or solution 44 from one of the containers 18 through the nozzle 26 (a), after which the second injection device 11 ejects the drug or solution 44 to the nozzle 26 (a).
- the drug or solution 44 is ejected from another one of the containers 18 through a).
- the igneous charge 20 for the first injection device 11 ejects the drug or solution 44 from one of the containers 18 through the nozzle 26 (a) and at the same time a second, perhaps adjacent injection.
- the device 11 ejects the drug or solution 44 from another one of the containers 18 through the nozzle 26 (a).
- Nozzles 26 (a)-(i) can extend at least partially beyond the downstream ends of two or more containers 18 (a)-(i). Nozzles 26 (a)-(i) may be configured to output the drug or solution 44 from two or more containers 18 (a)-(i). In some embodiments, the nozzles 26 (a)-(i) can output the drug or solution 44 in a pressurized manner. For example, nozzles 26 (a)-(i) can direct the pressurized agent or solution 44 to the patient's skin 13.
- the sizes of nozzles 26 (a)-(i) are selected based at least in part on the desired depth at which the agent penetrates (penetrates) the skin 13.
- the size of nozzles 26 (a)-(i) is preferably a jet of chemical or solution 44 exiting nozzles 26 (a)-(i) that achieves a desired depth of penetration through the skin 13. You can choose to achieve speed.
- the diameters of the nozzles 26 (a)-(i) are such that the two or more containers 18 (a) have at least a plurality of fire charge 20 (a)-(i) undetonated. It is smaller than the diameter of (i).
- the nozzles 26 (a)-(i) can output the drug or solution 44 in a predetermined direction.
- the nozzles 26 (a) to (i) can output the drug or solution 44 along the front-rear axis (vertical axis) of the nozzles 26 (a) to (i).
- nozzles 26 (a)-(i) can direct the agent or solution 44 to a predetermined position on the patient's skin 13.
- two or more of the nozzles 26 (a)-(i) are aligned to direct the agent or solution 44 to the same location on the patient's skin 13.
- the first nozzle 26 when one or more electronic components 22 detonate the first fire engineer charge 20, at least a portion of the first agent 44 is the first nozzle 26. It exits from and is arranged to penetrate the patient's skin 13.
- the second nozzle 26 when one or more electronic components 22 detonate the second fire engineer charge 20, at least a part of the second agent 44 is ejected from the second nozzle 26, and the patient's skin 13 It is arranged so as to penetrate through.
- the first nozzle 26 and the second nozzle 26 are located where at least a portion of the first agent 44 and at least a portion of the second agent 44 penetrate the patient's skin 13.
- first nozzle 26 and the second nozzle 26 are located where at least a portion of the first agent 44 and at least a portion of the second agent 44 penetrate the patient's skin 13. They are placed relative to each other so as to penetrate the patient's skin 13 at the same position as.
- the nozzles 26 (a)-(i) are manufactured as an integral element with two or more containers 18 (a)-(i).
- the nozzles 26 (a)-(i) can be formed by openings penetrating the walls of two or more containers 18 (a)-(i).
- the nozzles 26 (a)-(i) are manufactured as separate elements from the two or more containers 18 (a)-(i), followed by the two or more containers 18 (a). Positioned with respect to (i).
- the nozzles 26 (a)-(i) bond, ultrasonically weld, or clamp the nozzles 26 (a)-(i) to two or more containers 18 (a)-(i).
- separately manufactured nozzles 26 can be placed with respect to an opening penetrating the wall of the container 18.
- the inner diameter of the nozzle 26 is made smaller than the diameter of the opening in the wall of the container 18 so as to provide a narrower flow path that accelerates the jet of the drug or solution 44 exiting the container 18. be able to.
- the nozzles 26 (a) to (i) have a constant inner diameter.
- the nozzles 26 (a)-(i) have an inner diameter that converges in the direction of the flow (flow path).
- the nozzles 26 (a)-(i) have an inner diameter that diverges in the direction of the flow (flow path).
- the nozzles 26 (a)-(i) have an inner diameter that converges in the direction of flow and then diverges.
- the nozzles 26 (a)-(i) can have one or more polarizing plates (vane) formed in the internal flow path.
- the one or more deflectors are sized and shaped to straighten the solution 44 passing through the nozzle 26. The deflector can reduce turbulence in the solution 44 as the solution 44 is ejected from the nozzle 26.
- the nozzle 26 is formed as a screen (cover).
- the screen has multiple pores.
- the plurality of pores are micropores.
- each of the two or more containers 18 (a) to (i) includes a single nozzle 26.
- one container 18 can include a plurality of nozzles 26.
- each nozzle 26 may have the same or different size as the other nozzles 26 associated with the same container 18.
- FIG. 3 is a perspective exploded view of the patch 10 of FIG. 1, showing two or more containers 18 (a) to (i) before being inserted into the clamp sheet 50.
- FIG. 3 further shows the laminated arrangement of the clamp sheet 50, the sheet 40, and the mask layer 36 above the plurality of fire charge 20 (a) to (i). Also shown is an embodiment in which the removable release liner 48 is placed above the patch 10.
- the patch 10 comprises a printed circuit board (PCB) or circuit board 28 that supports a plurality of fire engine charges 20 (a)-(i).
- the circuit board 28 is flexible so that the bottom surface 14 of the base 12 can be adapted (matched) to the surface of the patient's limbs or torso.
- the circuit board 28 does not have to be flexible.
- the circuit board 28 may be curved to the extent that it comes into contact with the skin 13 or have such flexibility.
- the small patch 10 may have less flexibility or curvature because the contact surface on the skin 13 is similarly small.
- the circuit board 28 further supports one or more electronic components 22.
- the circuit board 28 extends at least one trace 32 between one or more electronic components 22 and each of the plurality of pyrotechnic agents 20 (a)-(i). (A) to (i) are provided.
- at least one wiring 32 (a)-(i) allows one or more electronic components 22 to individually detonate each of the plurality of fire engine charges 20 (a)-(i). It is composed of.
- one or more electronic components 22 and a plurality of fire charge 20 (a)-(i) are one without using at least one wiring 32 (a)-(i).
- the plurality of electronic components 22 are arranged so as to be directly electrically connected to the plurality of fire engine charges 20 (a) to (i).
- At least one wiring 32 (a)-(i) is used, at least one wiring 32 (a)-(i) is a plurality of electronic components 22 on the circuit board 28. Any route between the fireworks charge 20 (a) to (i) can be followed.
- the portion 30 of at least one wiring 32 (a) to (i) extends substantially longitudinally toward the respective fire engine charge 20 with each wiring 32 turning individually. It extends laterally from one or more electronic components 22 prior to this.
- Each wire 32 can include two separate wires for completing at least a portion of an electrical circuit having one or more electronic components 22.
- each fire charge 20 is associated with two wires in each wire 32.
- the two wires 32 or wires form part of an electrical circuit between each of the one or more electronic components 22 and the plurality of fire charge 20s.
- patch 10 comprises a clamp sheet 50.
- the clamp sheet 50 supports two or more containers 18 (a)-(i).
- two or more containers 18 (a)-(i) are inserted into the individual recesses 56 (a)-(i) of the clamp sheet 50.
- each recess 56 (a) to (i) is formed as a stagnant portion of the clamp sheet 50.
- each stagnant portion is sized and shaped to roughly coincide with the outer surfaces of two or more containers 18 (a)-(i).
- the top opening (closest to the sheet 40) in the recesses 56 (a)-(i) clamps two or more containers 18 (a)-(i) during assembly of the sheet 50. It has a size that facilitates insertion into the recesses 56 (a) to (i). In certain embodiments, the opening (at the top of the recess 56) has a diameter greater than or equal to the maximum diameter of the two or more containers 18 (a)-(i).
- the opening at the top of the recess 56 has a diameter slightly smaller than the maximum diameter of the two or more containers 18 (a)-(i), but during assembly, 2 It is still possible to insert one or more containers 18 (a)-(i) into the recesses 56 (a)-(i) of the clamp sheet 50.
- each recess 56 (a)-(i) are provided with an opening that penetrates the clamp sheet 50.
- the opening (on the bottom surface of the recess 56) is sized smaller than the diameter of the two or more containers 18 (a)-(i). In this way, when the plurality of fire engine charges 20 (a) to (i) deform the two or more containers 18 (a) to (i) to eject the solution 44, the two or more containers It is suppressed that 18 (a) to (i) pass through the opening (on the bottom surface) of the clamp sheet 50.
- patch 10 comprises sheet 40.
- the sheet 40 comprises a polymeric material. In certain other embodiments, the sheet 40 comprises a non-polymeric material. In a particular embodiment, the sheet 40 is arranged on opposite sides of the two or more containers 18 (a)-(i) with respect to the clamp sheet 50. In certain embodiments, the sheet 40 is joined to the clamp sheet 50 by, for example, ultrasonic welding, bonding, clipping (clamping), and clamping (clamping). When assembled, the sheet 40 provides a barrier between the plurality of fireworks charges 20 (a)-(i) and the two or more containers 18 (a)-(i).
- the sheet 40 comprises one or more diaphragms 42 (a)-(i).
- each diaphragm 42 (a)-(i) is associated with one of two or more containers 18 (a)-(i).
- each diaphragm 42 (a)-(i) is associated with two or more of two or more containers 18 (a)-(i).
- the sheet 40 includes a single diaphragm 42 and a peripheral portion surrounding the single diaphragm 42.
- the diaphragms 42 (a)-(i) have flexibility.
- the diaphragms 42 (a)-(i) are more flexible than the rest of the sheet 40 (parts other than the diaphragm 42).
- the diaphragms 42 (a)-(i) are as flexible as the rest of the sheet 40.
- the flexibility of the diaphragms 42 (a)-(i) is such that the diaphragm 42 responds to the pressure spikes generated by the plurality of fire fillers 20 (a)-(i) in the recess 56 (a) of the clamp sheet 50. It may be possible to project into (i) and compress two or more containers 18 (a)-(i).
- the sheet 40 is generally flat and has a constant thickness throughout the sheet 40. In certain embodiments, the sheet 40 is generally flat except for the regions of diaphragms 42 (a)-(i). In certain embodiments, the thickness of the sheet 40 in the regions of diaphragms 42 (a)-(i) is less than the thickness of the rest of the sheet 40. In certain embodiments, the regions of the diaphragms 42 (a)-(i) have a dome shape. In certain embodiments, the regions of the diaphragms 42 (a)-(i) substantially match the shape of the portion of the two or more containers 18 (a)-(i) adjacent to the diaphragm 42 when assembled. Has a shape.
- patch 10 comprises a mask layer 36.
- the mask layer 36 forms a spacer between the circuit board 28 and the two or more containers 18 (a)-(i).
- the mask layer 36 forms a barrier between adjacent fireworks charges 20 (a)-(i). In certain embodiments, the barrier prevents one injection device 11 from sympathetically (interlocking) operating another injection device 11.
- the mask layer 36 comprises one or more chambers 38.
- each chamber 38 has a cylindrical shape. In certain other embodiments, each chamber 38 has a square or any other shape. In certain embodiments, each of the one or more chambers 38 is associated with one injection device 11. In the illustrated embodiment, each of the one or more chambers 38 (a)-(i) is associated with one of the plurality of fire charge 20 (a)-(i).
- each of one or more chambers 38 (a)-(i) has an open top and an open bottom. In certain embodiments, one or both of the tops and bottoms of one or more chambers 38 (a)-(i) are closed. In the illustrated embodiment, one or more chambers 38 (a)-(i) extend away from the circuit board 28. In another embodiment, the mask layer 36 is turned upside down with respect to the embodiment shown in FIG. 3, and in such an embodiment, one or more chambers 38 (a)-(i) are It extends in the direction toward the circuit board 28.
- the mask layer 36 is bonded to or otherwise attached to the circuit board 28 via ultrasonic welding, bonding, clipping, clamping, or other attachment means. In one embodiment, the mask layer 36 is compressed between the sheet 40 and the circuit board 28. In certain embodiments, the mask layer 36 is bonded to the sheet 40 by ultrasonic welding, bonding, clipping, clamping, or other mounting means, or is otherwise mounted. In certain embodiments, the mask layer 36 comprises a polymeric material. Of course, the present disclosure is not so limited, and the mask layer 36 can be made from a non-polymeric material.
- FIG. 4 is a cross-sectional view of the patch 10 as viewed along the cut plane 4-4 in FIG. 2, a nozzle 26 covered with a removable release liner 48 before the patch 10 is attached to the patient's skin 13 ( d), 26 (e) and 26 (f) are shown.
- the seal 46 is located within nozzles 26 (a)-(i). The seal 46 prevents the solution 44 from leaking from the two or more containers 18 (a)-(i) when the injection device 11 is not operating. Once the injection device 11 is activated, the pressure in the two or more containers 18 (a)-(i) caused by the compression of the container 18 breaks the seal 46 and allows the solution 44 to pass through and exit the nozzle 26. To enable.
- patch 10 comprises a plurality of resistance wires 34 (a)-(i).
- FIG. 4 shows the resistance wires 34 (d), 34 (e), and 34 (f).
- the resistance wires 34 (a)-(i) are in contact with the plurality of fire fillers 20 (a)-(i).
- the resistance wire 34 (d) is in contact with the fire filler 20 (d).
- the resistance wire 34 (e) is in contact with the fire filler 20 (e).
- the resistance wire 34 (f) is in contact with the fire filler 20 (f).
- each wire 32 (ie, wire 32 (e)) may include two separate wires for completing at least a portion of an electrical circuit having one or more electronic components 22. ..
- one or more electronic components 22 can be electrically connected to one end of each of the two wires of wiring 32 (d).
- Each end of the resistor wire 34 (d) can then be electrically connected to one of the other ends of each of the two wires of the wiring 32 (d) that completes the electrical circuit.
- the resistor wire 34 has a diameter of 20 microns. In some embodiments, the resistor wire 34 has a length of 0.5 mm. In certain embodiments, the resistor wire 34 has a resistance (value) of 1 ohm. Of course, this disclosure is not so limited.
- the resistance wires 34 (a)-(i) can have any length, diameter, and / or resistance value.
- the release liner 48 is removed, one of the plurality of fire charge 20 (e) is detonated, and the solution 44 is ejected (released) from the nozzle 26 (e) into the patient's skin 13.
- the pressure from the burning fire charge 20 (e) further moves or presses a part of the container 18 (e) into the recesses 56 (a) to (i) of the clamp sheet 50. Increase the pressure in the container 18 (e).
- the fire charge 20 (e) provides pressure to push out a jet of solution 44 that enters or penetrates the skin 13 through the nozzle 26 (e).
- the burned fire charge 20 (e) itself does not pass through the nozzle 26 (e), does not enter the skin 13, and does not penetrate it.
- the burned fire charge 20 (e) is housed in patch 10.
- the post-combustion fire charge 20 (e) can leak through the nozzle 26 (e), but its velocity is sufficiently damped so that it does not enter the skin 13. ..
- the solution 44 when the solution 44 is ejected from the container 18 (e), one or both of the walls of the sheet 40 and the container 18 (e) do not rupture, but the burned fire charge 20 (e) and the patient's. Maintains a barrier to the skin 13.
- both the sheet 40 and the wall of the container 18 (e) burst, but due to the size and shape of the burst, for example, the burnt fireworks. The rate at which the burned fireworks charge 20 (e) leaks is sufficiently attenuated so that the medicine 20 (e) does not enter the skin 13.
- the source of the force that causes the solution 44 to enter the skin 13 is still the propulsive force (momentum) of the solution 44 itself, and the post-combustion fire engine charge 20 that may have leaked from the patch 10 ( It is not an accidental contact between any of e) and the skin 13.
- the heights of the chambers 38 (a)-(i) are the containers 18 (a)-(" with two or more pressures from the burning fireworks charge 20 (a)-(i). Multiple igneous charge 20 (a) with sufficient space to allow the two or more containers 18 (a)-(i) to release the solution 44 to be properly compressed without rupturing i). )-(I) and the sheet 40 are selected to provide. In certain embodiments, the heights of chambers 38 (a)-(i) are such that the pressure from the burning fireworks 20 (a)-(i) does not cause the sheet 40 to burst.
- Sufficient space is provided between the plurality of fire engine charges 20 (a) to (i) and the sheet 40 to allow the two or more containers 18 (a) to (i) to be discharged to be appropriately compressed. Is selected to provide.
- the height of the chamber 38 is the pressure from the burning fire charge 20 (a)-(i) of the sheet 40 and the two or more containers 18 (a)-(i).
- a plurality of fire engine charges 20 (a) are provided with sufficient space to allow the two or more containers 18 (a)-(i) to release the solution 44 to be appropriately compressed without bursting any of the above. )-(I) and the sheet 40 are selected to provide.
- the height of the chamber 38 attenuates the pressure of the in-combustion fire charge 20 that can leak through the rupture of the sheet 40 and the containers 18 (a)-(i) while allowing the solution 44 to flow.
- Sufficient space is provided between the plurality of fire engine charges 20 (a) to (i) and the sheet 40 to allow the two or more containers 18 (a) to (i) to be discharged to be appropriately compressed. Is selected to provide.
- FIG. 6 shows a first component assembly (subassembly) of patch 10 comprising one or more electronic components 22, a plurality of fire fillers 20 (a)-(i), a mask layer 36, and a sheet 40. It is an exploded perspective view.
- the mask layer 36 includes a plurality of chambers 38 (a)-(i) for the plurality of fire charge 20 (a)-(i).
- FIG. 7A is a cross-sectional view of the first component assembly of FIG. 6 as viewed along the cut surface 7A-7A of FIG. 6, and the firework charge 20 (b) assembled on the lower surface of the mask layer 36.
- the circuit board 28 supporting the above is shown.
- the sheet 40 is shown assembled on the upper surface of the mask layer 36 so that the diaphragm 42 (b) in the sheet 40 is aligned with the chamber 38 (b) of the mask layer 36.
- FIG. 7B is a cross-sectional view similar to FIG. 7A except that the circuit board 28 is assembled on the lower surface of the mask layer 36 and the sheet 40 is assembled on the upper surface of the mask layer 36.
- one or all of the components of the first component assembly are joined together, for example, by ultrasonic welding, bonding, clipping, or clamping.
- FIG. 8 is a perspective exploded view of the second first component assembly (subassembly) of the patch 10 including the clamp sheet 50 and two or more containers 18 (a) to (i).
- the two or more containers 18 (a) to (i) are aligned with the recesses 56 (a) to (i) of the clamp sheet 50.
- the removable release liner 48 is shown placed above the clamp sheet 50.
- the patch 10 comprises an adhesive layer 54.
- the adhesive layer 54 is configured to secure the patch 10 to the patient's skin 13.
- the adhesive layer 54 is configured to allow the patch 10 to be fixed (continuously) to the patient's skin 13 for a period of time.
- the release liner 48 includes a tab 52 to facilitate removal of the release liner 48 from the clamp sheet 50.
- the patch 10 comprises a strap attached to the base 12. The straps are configured to be secured around the patient's limbs or torso so as to maintain contact between the patient's skin 13 and the inferior surface 14.
- 9A is a cross-sectional view of the second component assembly of FIG. 8 as viewed along the cut surface 9A-9A of FIG. 8, and is one of the recesses 56 (a) to (i) of the clamp sheet 50.
- the container 18 (b) incorporated in one is shown.
- the release liner 48 is shown above the clamp sheet 50.
- FIG. 9B has a cross section similar to that of FIG. 9A, except that the container 18 (b) is inserted into the recesses 56 (a) to (i) of the clamp sheet 50 and the release liner 48 is attached to the clamp sheet 50. It is a figure.
- one or all of the components of the second component assembly are joined together, for example, by ultrasonic welding, bonding, clipping, or clamping.
- the first component assembly of FIG. 7B and the second component assembly of FIG. 9B are joined together by, for example, ultrasonic welding, bonding, clipping, or clamping and are shown in FIG.
- the final assembly of the patch 10 is formed as described above.
- the method for manufacturing patch 10 is initiated by providing a first component assembly as shown in FIG. 7B.
- the first component assembly has a bottom surface, an upper surface, and two or more containers 18 (a) to (i) arranged between the bottom surface and the upper surface.
- the bottom surface is configured to be positioned relative to the patient's skin 13.
- each container 18 in two or more containers 18 (a)-(i) comprises a solution or drug 44.
- This method subsequently provides a second component assembly as shown in FIG. 9B.
- the second component assembly has a plurality of chambers 38 (a)-(i).
- each chamber 38 in the plurality of chambers 38 (a)-(i) comprises one of the plurality of fire charge 20 (a)-(i).
- This method subsequently assembles a second component such that the plurality of chambers 38 (a)-(i) are located on opposite sides of the two or more containers 18 (a)-(i) when viewed from the bottom.
- the product is joined to the top surface of the first parts assembly.
- the plurality of chambers 38 (a)-(i) have two or more containers 18 (a)-(i) when at least the second assembly is joined to the first assembly. Aligned with (i).
- This method subsequently bonds the first and second component assemblies to each other, for example by ultrasonic welding, bonding, clipping, or clamping, to form the final assembly.
- FIG. 10 shows another embodiment of two or more containers 18 (a) to (i) of FIG. 4 having a truncated triangular shape.
- FIG. 11 shows another embodiment of two or more containers 18 (a)-(i) of FIG. 4 having a truncated pentagonal shape.
- the shapes of the two or more containers 18 (a) to (i) are not limited to the disclosed shapes, and may have any shape instead.
- a base having a bottom surface and a top surface, wherein the bottom surface is configured to be disposed with respect to the patient's skin.
- a first container supported by the base and containing a first drug
- a second container supported by the base and containing a second drug
- a first igneous charge disposed between the upper surface and the first container in the base.
- a second igneous charge disposed between the upper surface and the second container in the base.
- Wearable multi-shot injection patch With one or more electronic components configured to detonate the first fire charge and the second fire charge.
- In the first nozzle when the one or more electronic components detonate the first fire charge, at least a part of the first drug is ejected from the first nozzle to the patient.
- Arranged to penetrate the skin of The second nozzle ejects at least a portion of the second agent from the second nozzle when the one or more electronic components detonate the second fire charge.
- a wearable multi-shot injection patch according to Appendix 2 which is placed so as to penetrate the skin of the skin.
- the first nozzle and the second nozzle of the patient are located at positions where at least a part of the first drug is different from the position where at least a part of the second drug penetrates the skin of the patient.
- the first nozzle and the second nozzle are located in the same position where at least a part of the first agent penetrates the skin of the patient and at least a part of the second agent penetrates the skin of the patient.
- the wearable multi-shot injection patch according to Appendix 3 which is arranged relative to each other so as to penetrate the skin.
- Appendix 6 The wearable according to any of Appendix 1-5, wherein the base has a circuit board and the bottom surface of the circuit board is flexible so that it can fit the surface of the patient's limbs or torso. Multi-shot injection patch.
- Appendix 7) The wearable multi-shot injection patch according to any one of Appendix 1 to 6, wherein the base comprises an adhesive layer configured to allow the wearable multi-shot injection patch to adhere to the patient's skin.
- Appendix 8 Any of Appendix 1-7, further comprising a strap that is connected to the base and can be secured around the patient's limbs or torso so that contact between the bottom surface and the patient's skin is maintained.
- Described wearable multi-shot injection patch (Appendix 9) The one or more electronic components according to any one of Supplementary notes 1 to 8, wherein the one or more electronic components are configured to generate an electric current for detonating the first fire charge and the second fire charge.
- Wearable multi-shot injection patch (Appendix 10) The wearable according to any one of Supplementary Notes 1 to 9, wherein the one or more electronic components are configured to selectively detonate the first fire charge and the second fire charge. Multi-shot injection patch.
- the one or more electronic components include a microcontroller so that the microcontroller stores an instruction to detonate at least one of the first fire charge and the second fire charge. Consists of a wearable multi-shot injection patch according to any of supplementary notes 1-14.
- the one or more electronic components include a timer, and the microcontroller at least partially based on the timer to provide at least one of the first fire charge and the second fire charge.
- the wearable multi-shot injection patch according to any of supplementary notes 1 to 17, further comprising a battery configured to power the one or more electronic components.
- the one or more electronic components include a receiver configured to receive the radio signal, the first or more electronic components being at least partially based on the radio signal.
- Appendix 20 The wearable multi-shot injection patch according to Appendix 19, wherein the receiver is configured to receive the radio signal from the patient.
- (Appendix 24) The wearable according to any of Supplementary notes 1 to 23, wherein the base comprises at least one first wire extending between the one or more electronic components and the second fire engineer. Multi-shot injection patch. (Appendix 25) 23. The wearable multi-shot injection patch according to Appendix 23, wherein the base further comprises a resistance wire that is in contact with and electrically connected to the first wire. (Appendix 26) The wearable multi-shot injection patch according to Appendix 24, wherein the base further comprises a resistance wire that is in contact with and electrically connected to the second wire. (Appendix 27) The wearable multi-shot injection patch according to Appendix 25 or 26, wherein the resistance wire has a diameter of 20 microns.
- the base comprises a mask layer forming a first chamber and a second chamber.
- the first fire charge is placed in the first chamber and the second fire charge is placed in the second chamber.
- At least a portion of the first chamber and at least a portion of the second chamber form a barrier between the first fire charge and the second fire charge, according to appendices 1-31.
- a wearable multi-shot injection patch as described in either. (Appendix 33) The wearable multi-shot injection patch according to Appendix 32, wherein the mask layer comprises a polymeric material.
- the base further comprises a sheet disposed between the mask layer and both the first container and the second container.
- Multi-shot injection patch (Appendix 35) The wearable multi-shot injection patch of Appendix 34, wherein the sheet and the mask layer are bonded to each other by any of ultrasonic welding, bonding, clipping, and clamping. (Appendix 36) The wearable multi-shot injection patch according to Appendix 34 or 35, wherein each of the first diaphragm and the second diaphragm has a dome shape. (Appendix 37) The wearable multi-shot injection patch according to Appendix 36, wherein each of the first container and the second container has a spherical shape.
- the first fire charge causes a pressure spike to move the first diaphragm towards the first container.
- the first diaphragm is flexible so that at least a part of the first drug is ejected from the first container.
- the second fire charge causes a pressure spike to move the second diaphragm towards the second container.
- the second diaphragm is flexible so as to eject at least a part of the second drug from the second container.
- the wearable multi-shot injection patch according to any of Supplementary notes 1 to 38, wherein the first container and the second container are at least partially located within the base.
- the first container is formed and further includes an outer wall having a first opening, and the first nozzle is arranged in the first opening. It further comprises an outer wall having a second opening as well as forming the second container, the second nozzle being arranged in the second opening.
- Appendix 41 So that at least a portion of the first agent ejected from the first nozzle forms a jet of liquid at a first position that is fast enough to penetrate the patient's skin to a desired depth.
- the size and shape of the first nozzle is determined, So that at least a portion of the second agent ejected from the second nozzle forms a jet of liquid at a second position that is fast enough to penetrate the patient's skin to a desired depth.
- the size and shape of the second nozzle is fixed, A wearable multi-shot injection patch according to Appendix 2 or 40.
- Appendix 42 A plurality of wearable multi-shot injection patches according to any of Appendix 1 to 41, wherein the base further comprises a clamp sheet, wherein the first container and the second container are located within the clamp sheet.
- Appendix 49 The multi-shot injection patch according to Appendix 47 or 48, wherein the second component assembly is bonded to the first component assembly by any of ultrasonic welding, bonding, clipping, and clamping. Production method.
- Appendix 50 A method of injecting a drug through the patient's skin using a wearable patch with a bottom and a top surface. A plurality of containers and a plurality of chambers aligned with the plurality of containers are included, the plurality of containers are arranged between the bottom surface and the top surface, and each container stores a drug, and the plurality of chambers.
- Affixing the bottom surface of the wearable patch to the patient's skin, each of which is located between the plurality of containers and the top surface and each chamber has a blazing charge. Detonating the fire engine charge in at least one of the plurality of chambers, compressing at least one of the plurality of containers, and ejecting the drug from at least the container through the patient's skin.
- Injecting methods including.
- Explosive charge Includes a structure that prevents the gunpowder from coming into contact with the skin and / or 11) a structure that prevents the explosive from mixing with the drug. Therefore, protection is not limited to the details of the embodiments described above. Protection is any new or any new combination of features disclosed herein (including claims, abstracts, and drawings), or steps in the methods or processes so disclosed. Extends to any new one, or any new combination of.
- steps may be shown in the drawings or described herein in a particular order, but such steps are shown in a particular order or in a contiguous order to achieve the desired result. Not all steps need to be performed. Other steps not shown or described can be incorporated into exemplary methods and processes. For example, one or more additional steps can be performed before, after, at the same time, or in between of the steps described. In addition, the steps may be rearranged or rearranged in other practices. Those skilled in the art will appreciate that in some embodiments, the actual steps taken in the illustrated and / or disclosed process may differ from those illustrated. Depending on the embodiment, some of the above steps can be omitted and other steps can be added.
- the term “horizontal” as used herein refers to the floor or ground plane of the area in which the device described or the method described is performed, regardless of its orientation. Or defined as a plane parallel to the surface.
- the term “floor” can be replaced by the term “ground”.
- the term “vertical”, as defined, refers to the direction perpendicular to the horizontal. "Above”, “below”, “bottom”, “top”, “side”, “higher”, “lower”, “ Terms such as “upper”, “over” and “under” are defined for the horizontal plane.
- conditional terms used herein such as “can,” “could,” “might, may,” and “eg,” are particularly specific. Unless otherwise stated or understood in other contexts in the context in which it is used, it generally conveys that a particular embodiment includes certain features, elements, and / or steps, but not other embodiments. Is intended to be. Thus, such conditional terms are generally such that features, elements, and / or steps are somehow required in one or more embodiments, or one or more embodiments are other. To determine whether these features, elements, and / or steps, with or without input or instructions, are included in any particular embodiment or should be performed in any particular embodiment. It does not imply that it necessarily contains logic.
- the "language of degree” used herein, such as the terms “approximately,” “about,” “generally,” and “substantially,” as used herein, is the value given. Represents a value, quantity, or characteristic that is close to or close to a quantity, or characteristic, and still performs the desired function or achieves the desired result.
- the terms “approximately,” “about,” “generally,” and “substantially” are less than 10%, less than 5%, less than 1%, less than 0.1%, and of the stated amounts. It may refer to an amount in the range of less than 0.01%.
- the terms "generally parallel” and “substantially parallel” are strictly parallel to 15 degrees, 10 degrees, 5 degrees, 3 degrees, 1 degree, 0.1. Refers to a value, quantity, or characteristic that deviates from a perfect fifth or less.
- multi-shot patches have been disclosed in the context of specific embodiments and examples, multi-shot patches and subassemblies go beyond the specifically disclosed embodiments to other alternative embodiments and / of embodiments. Or it will be understood by those skilled in the art to extend to its use, as well as its variants and equivalents. Therefore, the scope of the multi-shot patch disclosed herein should not be limited by the particular disclosed embodiments described above, but should only be determined by fair reading of the following claims.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
(付記1)
底面および上面を有する基部であって、前記底面が患者の皮膚に対して配置されるように構成される、基部と、
前記基部によって支持され、第1の薬剤を収容する第1の容器と、
前記基部によって支持され、第2の薬剤を収容する第2の容器と、
前記基部内において前記上面および前記第1の容器の間に配置された第1の火工装薬と、
前記基部内において前記上面と前記第2の容器の間に配置された第2の火工装薬と、
前記第1の火工装薬および第2の火工装薬を起爆するように構成された1つまたは複数の電子部品と、
を備える、着用可能なマルチショット注射パッチ。
(付記2)
前記第1の火工装薬および第2の火工装薬を起爆するように構成された1つまたは複数の電子部品と、
前記基部によって支持され、前記第1の火工装薬からみて前記第1の容器の反対側に配置された第1のノズルと、
前記基部によって支持され、前記第2の火工装薬からみて前記第2の容器の反対側に配置された第2のノズルと、
を更に備える、付記1に記載の着用可能なマルチショット注射パッチ。
(付記3)
前記第1のノズルは、前記1つまたは複数の電子部品が前記第1の火工装薬を起爆するときに、前記第1の薬剤の少なくとも一部が前記第1のノズルから射出して前記患者の皮膚を貫通するように配置され、
前記第2のノズルは、前記1つまたは複数の電子部品が前記第2の火工装薬を起爆するときに、前記第2の薬剤の少なくとも一部が前記第2のノズルから射出して前記患者の皮膚を貫通するように配置される、付記2に記載の着用可能なマルチショット注射パッチ。
(付記4)
前記第1のノズルおよび前記第2のノズルは、前記第1の薬剤の少なくとも一部が、前記第2の薬剤の少なくとも一部が前記患者の皮膚を貫通する位置とは異なる位置で前記患者の皮膚を貫通するように、それぞれ相対的に配置される、付記3に記載の着用可能なマルチショット注射パッチ。
(付記5)
前記第1のノズルおよび前記第2のノズルは、前記第1の薬剤の少なくとも一部が、前記第2の薬剤の少なくとも一部が前記患者の皮膚を貫通するのと同じ位置で前記患者の皮膚を貫通するように、それぞれ相対的に配置される、付記3に記載の着用可能なマルチショット注射パッチ。
(付記6)
前記基部は回路基板を有し、前記回路基板の底面が、患者の肢または胴体の表面に適合することができるように可撓性を有する、付記1から5の何れかに記載の着用可能なマルチショット注射パッチ。
(付記7)
前記基部が、前記着用可能なマルチショット注射パッチを前記患者の皮膚に接着可能に構成された接着層を含む、付記1から6の何れかに記載の着用可能なマルチショット注射パッチ。
(付記8)
前記基部に連結され、前記底面と前記患者の皮膚との間の接触が維持されるように前記患者の肢または胴体の周りに固定可能なストラップを、更に備える、付記1から7の何れかに記載の着用可能なマルチショット注射パッチ。
(付記9)
前記1つまたは複数の電子部品は、前記第1の火工装薬および前記第2の火工装薬を起爆するための電流を生成するように構成される、付記1から8の何れかに記載の着用可能なマルチショット注射パッチ。
(付記10)
前記1つまたは複数の電子部品は、前記第1の火工装薬および前記第2の火工装薬を選択的に起爆するように構成される、付記1から9の何れかに記載の着用可能なマルチショット注射パッチ。
(付記11)
前記1つまたは複数の電子部品は、前記第1の火工装薬および前記第2の火工装薬のそれぞれを独立して起爆するように構成される、付記1から9の何れかに記載の着用可能なマルチショット注射パッチ。
(付記12)
前記1つまたは複数の電子部品は、前記第1の火工装薬および前記第2の火工装薬の双方を同時に起爆するように構成される、付記1から9の何れかに記載の着用可能なマルチショット注射パッチ。
(付記13)
前記1つまたは複数の電子部品は、遠隔制御されるように構成される、付記1から12の何れかに記載の着用可能なマルチショット注射パッチ。
(付記14)
前記1つまたは複数の電子部品は、所定の時系列で制御されるように構成される、付記1から12の何れかに記載の着用可能なマルチショット注射パッチ。
(付記15)
前記1つまたは複数の電子部品はマイクロコントローラを備え、前記マイクロコントローラは前記第1の火工装薬および前記第2の火工装薬のうちの少なくとも何れかを起爆するための命令を記憶するように構成される、付記1から14の何れかに記載の着用可能なマルチショット注射パッチ。
(付記16)
前記命令は、前記第1の火工装薬と前記第2の火工装薬とを起爆する間隔を指定する、付記15に記載の装着可能なマルチショット注射パッチ。
(付記17)
前記1つまたは複数の電子部品はタイマーを備え、前記マイクロコントローラは、前記タイマーに少なくとも部分的に基づいて、前記第1の火工装薬および前記第2の火工装薬のうちの少なくとも何れかを起爆するように構成される、付記15または16に記載の着用可能なマルチショット注射パッチ。
(付記18)
前記1つまたは複数の電子部品に電力を供給するように構成されたバッテリを更に備える、付記1から17の何れかに記載の着用可能なマルチショット注射パッチ。
(付記19)
前記1つまたは複数の電子部品は、無線信号を受信するように構成された受信機を備え、前記1つまたは複数の電子部品は、前記無線信号に少なくとも部分的に基づいて、前記第1の火工装薬および前記第2の火工装薬のうちの少なくとも何れかを起爆するように構成される、付記1から18の何れかに記載の着用可能なマルチショット注射パッチ。
(付記20)
前記受信機は、前記患者からの前記無線信号を受信するように構成される、付記19に記載の着用可能なマルチショット注射パッチ。
(付記21)
前記受信機は、医療専門家からの前記無線信号を受信するように構成される、付記19に記載の着用可能なマルチショット注射パッチ。
(付記22)
前記患者が、前記第1の火工装薬および前記第2の火工装薬のうちの少なくとも何れかを起爆するために前記1つまたは複数の電子部品を起動するように構成されたユーザインタフェースを更に備える、付記1から21の何れかに記載の着用可能なマルチショット注射パッチ。
(付記23)
前記基部は、前記1つまたは複数の電子部品と前記第1の火工装薬との間に延在する少なくとも1つの第1の配線を備える、付記1から22の何れかに記載の着用可能なマルチショット注射パッチ。
(付記24)
前記基部は、前記1つまたは複数の電子部品と前記第2の火工装薬との間に延在する少なくとも1つの第1の配線を備える、付記1から23の何れかに記載の着用可能なマルチショット注射パッチ。
(付記25)
前記基部は、前記第1の火工装薬と接触すると共に前記第1の配線と電気的に接続された抵抗ワイヤ、を更に備える、付記23に記載の着用可能なマルチショット注射パッチ。
(付記26)
前記基部は、前記第2の火工装薬と接触すると共に前記第2の配線と電気的に接続された抵抗ワイヤ、を更に備える、付記24に記載の着用可能なマルチショット注射パッチ。
(付記27)
前記抵抗ワイヤは、20ミクロンの直径を有する、付記25または26に記載の装着可能なマルチショット注射パッチ。
(付記28)
前記抵抗ワイヤは、0.5mmの長さを有する、付記25から27の何れかに記載の装着可能なマルチショット注射パッチ。
(付記29)
前記抵抗ワイヤは、1オームの抵抗を有する、付記25から28の何れかに記載の装着可能なマルチショット注射パッチ。
(付記30)
前記第1の火工装薬および前記第2の火工装薬が、ジルコニウムおよび過塩素酸カリウムのうちの少なくとも何れかを含む、付記1から29の何れかに記載の着用可能なマルチショット注射パッチ。
(付記31)
前記第1の火工装薬および前記第2の火工装薬は、乾燥スラリーを含む、付記1から30の何れかに記載の着用可能なマルチショット注射パッチ。
(付記32)
前記基部は、第1のチャンバおよび第2のチャンバを形成するマスク層を含み、
前記第1の火工装薬は前記第1のチャンバ内に配置されると共に前記第2の火工装薬は前記第2のチャンバ内に配置され、
前記第1のチャンバの少なくとも一部および前記第2のチャンバの少なくとも一部は、前記第1の火工装薬と前記第2の火工装薬との間のバリアを形成する、付記1から31の何れかに記載の着用可能なマルチショット注射パッチ。
(付記33)
前記マスク層がポリマー材料を含む、付記32に記載の着用可能なマルチショット注射パッチ。
(付記34)
前記基部が、前記マスク層と前記第1の容器および前記第2の容器の双方との間に配置されたシートを更に備え、
前記シートが、前記第1のチャンバを覆うように配置された第1のダイヤフラムと、前記第2のチャンバを覆うように配置された第2のダイヤフラムを有する、付記32または33に記載の装着可能なマルチショット注射パッチ。
(付記35)
前記シートと前記マスク層とが、超音波溶接、接着、クリッピング、およびクランピングのうちの何れかによって互いに接合される、付記34に記載の装着可能なマルチショット注射パッチ。
(付記36)
前記第1のダイヤフラムおよび前記第2のダイヤフラムのそれぞれは、ドーム形状を有する、付記34または35に記載の装着可能なマルチショット注射パッチ。
(付記37)
前記第1の容器および前記第2の容器の各々が球形状を有する、付記36に記載の着用可能なマルチショット注射パッチ。
(付記38)
前記1つまたは複数の電子部品が前記第1の火工装薬を起爆するとき、前記第1の火工装薬が圧力スパイクを引き起こして前記第1のダイヤフラムを前記第1の容器に向かって移動させ、前記第1の容器から前記第1の薬剤の少なくとも一部を噴出するように前記第1のダイヤフラムが柔軟であり、
前記1つまたは複数の電子部品が前記第2の火工装薬を起爆するとき、前記第2の火工装薬が圧力スパイクを引き起こして前記第2のダイヤフラムを前記第2の容器に向かって移動させ、前記第2の容器から前記第2の薬剤の少なくとも一部を噴出するように前記第2のダイヤフラムが柔軟である、
付記34から37の何れかに記載の着用可能なマルチショット注射パッチ。
(付記39)
前記第1の容器および前記第2の容器は、少なくとも一部が前記基部内に配置される、付記1から38の何れかに記載の着用可能なマルチショット注射パッチ。
(付記40)
前記第1の容器を形成すると共に第1の開口部を有する外壁を更に備え、前記第1のノズルは前記第1の開口部に配置され、
前記第2の容器を形成すると共に第2の開口部を有する外壁を更に備え、前記第2のノズルは前記第2の開口部に配置される、
付記2に記載の着用可能なマルチショット注射パッチ。
(付記41)
前記第1のノズルから射出される前記第1の薬剤の少なくとも一部が第1の位置において所望の深さまで患者の皮膚を貫通するのに十分な速度を有する液体の噴流を形成するように、第1のノズルの大きさおよび形状が決められ、
前記第2のノズルから射出される前記第2の薬剤の少なくとも一部が第2の位置において所望の深さまで患者の皮膚を貫通するのに十分な速度を有する液体の噴流を形成するように、第2のノズルの大きさおよび形状が決められている、
付記2または40に記載の着用可能なマルチショット注射パッチ。
(付記42)
前記基部がクランプシートを更に備え、前記第1の容器および前記第2の容器が前記クランプシート内に配置される、付記1から41の何れかに複数の着用可能なマルチショット注射パッチ。
(付記43)
前記第1の薬剤が前記第2の薬剤と同一である、付記1から42の何れか1項に記載の着用可能なマルチショット注射パッチ。
(付記44)
前記第1の薬剤が前記第2の薬剤と異なる、付記1から43の何れかに記載の着用可能なマルチショット注射パッチ。
(付記45)
前記第1の薬剤は、前記第2の薬剤と相補的である、付記44に記載の着用可能なマルチショット注射パッチ。
(付記46)
前記1つまたは複数の電子部品は、第1の火工装薬および第2の火工装薬を同時にまたは連続的に起爆する、付記1から45に記載の着用可能なマルチショット注射パッチ。
(付記47)
着用可能なマルチショット注射パッチを製造する方法であって、
底面および上面を有し、且つ、前記底面と前記上面との間に配置された複数の容器を備え、前記底面が患者の皮膚に対して配置されるように構成され、前記複数の容器における各々が薬剤を収容する、第1の部品組立品を提供することと、
複数のチャンバを備え、前記複数のチャンバの各々が火工装薬を有する第2の部品組立品を提供することと、
前記複数のチャンバが前記底面からみて前記複数の容器の反対側に配置されるように、前記第2の部品組立品を前記第1の部品組立品における前記上面に接合することと、
を含む、マルチショット注射パッチの製造方法。
(付記48)
前記複数のチャンバは、少なくとも前記第2の部品組立品が前記第1の部品組立品に接合されるときに、前記複数の容器と整列される、付記47に記載のマルチショット注射パッチの製造方法。
(付記49)
前記第2の部品組立品は、超音波溶接、接着、クリッピング、およびクランピングのうちの何れかによって前記第1の部品組立品に接合される、付記47または48に記載のマルチショット注射パッチの製造方法。
(付記50)
底面および上面を有する着用可能なパッチを用いて患者の皮膚を通じて薬剤を注射する方法であって、
複数の容器と、前記複数の容器と整列した複数のチャンバと、を含み、前記複数の容器が前記底面と前記上面の間に配置されると共に各容器が薬剤を収容し、前記複数のチャンバの各々が前記複数の容器と前記上面との間に配置されると共に各チャンバが火工装薬を有する、前記着用可能なパッチの前記底面を前記患者の皮膚に貼り付けることと、
前記複数のチャンバのうちの少なくとも1つのチャンバ内で前記火工装薬を起爆し、前記複数の容器のうちの少なくとも1つの容器を圧縮して、前記薬剤を少なくとも容器から患者の皮膚を通して噴出させることと、
を含む、注射方法。
特定の実施形態および実施例が本明細書に開示されているが、本発明の主題は、具体的に開示された実施形態における実施例を超えて、他の代替の実施形態および/または使用、ならびにそれらの改変および均等物に及ぶ。したがって、本明細書に添付されたクレームの範囲は、上述の特定の実施形態のいずれによっても限定されない。例えば、本明細書に開示される任意の方法またはプロセスにおいて、方法またはプロセスの動作または工程(操作)は、任意の適切な順序で実行されてもよく、必ずしも特定の開示された順序に限定されない。様々な工程(操作)は、特定の実施形態を理解するのに役立ち得る方法で、複数の別々の工程(操作)として順番に説明され得るが、その説明の順序は、これらの工程(操作)が順序に依存することを暗示するように解釈されるべきではない。更に、本明細書に記載される構造、システム、および/または装置は、統合されたコンポーネントとして、または別個のコンポーネントとして具現化され得る。様々な実施形態を比較する目的で、これらの実施形態における特定の態様および利点が説明される。したがって、例えば、種々の実施形態は、本明細書で教示または示唆され得るような他の態様または利点を必ずしも達成することなく、本明細書で教示されるような1つの態様、利点、または一群の利点を達成または最適化する方法で実行され得る。
11・・・注射装置
12・・・基部
18・・・容器
20・・・火工装薬
22・・・電子部品
26・・・ノズル
28・・・回路基板
32・・・配線
36・・・マスク層
38・・・チャンバ
40・・・シート
42・・・ダイヤフラム
50・・・クランプシート
Claims (17)
- 底面および上面を有する基部であって、前記底面が患者の皮膚に対して配置されるように構成される、基部と、
前記基部によって支持され、第1の薬剤を収容する第1の容器と、
前記基部によって支持され、第2の薬剤を収容する第2の容器と、
前記基部内において前記上面および前記第1の容器の間に配置された第1の火工装薬と、
前記基部内において前記上面と前記第2の容器の間に配置された第2の火工装薬と、
前記第1の火工装薬および第2の火工装薬を起爆するように構成された1つまたは複数の電子部品と、
を備える、着用可能なマルチショット注射パッチ。 - 前記基部によって支持され、前記第1の火工装薬からみて前記第1の容器の反対側に配置された第1のノズルと、
前記基部によって支持され、前記第2の火工装薬からみて前記第2の容器の反対側に配置された第2のノズルと、
を更に備える、請求項1に記載の着用可能なマルチショット注射パッチ。 - 前記基部は回路基板を有し、前記回路基板の底面が、患者の肢または胴体の表面に適合することができるように可撓性を有する、請求項1または2に記載の着用可能なマルチショット注射パッチ。
- 前記基部が、前記着用可能なマルチショット注射パッチを前記患者の皮膚に接着可能に構成された接着層を含む、請求項1から3の何れか1項に記載の着用可能なマルチショット注射パッチ。
- 前記基部に連結され、前記底面と前記患者の皮膚との間の接触が維持されるように前記患者の肢または胴体の周りに固定可能なストラップを、更に備える、請求項1から4の何れか1項に記載の着用可能なマルチショット注射パッチ。
- 前記1つまたは複数の電子部品は、前記第1の火工装薬および前記第2の火工装薬を選択的に起爆するように、または、双方を同時に起爆するように構成される、請求項1から5の何れか1項に記載の着用可能なマルチショット注射パッチ。
- 前記1つまたは複数の電子部品は、遠隔制御されるように、または所定の時系列で制御されるように構成される、請求項1から6の何れか1項に記載の着用可能なマルチショット注射パッチ。
- 前記1つまたは複数の電子部品はマイクロコントローラを備え、前記マイクロコントローラは前記第1の火工装薬および前記第2の火工装薬のうちの少なくとも何れかを起爆するための命令を記憶するように構成される、請求項1から7の何れか1項に記載の着用可能なマルチショット注射パッチ。
- 前記1つまたは複数の電子部品は、無線信号を受信するように構成された受信機を備え、前記1つまたは複数の電子部品は、前記無線信号に少なくとも部分的に基づいて、前記第1の火工装薬および前記第2の火工装薬のうちの少なくとも何れかを起爆するように構成される、請求項1から8の何れか1項に記載の着用可能なマルチショット注射パッチ。
- 前記基部は、第1のチャンバおよび第2のチャンバを形成するマスク層を含み、
前記第1の火工装薬は前記第1のチャンバ内に配置されると共に前記第2の火工装薬は前記第2のチャンバ内に配置され、
前記第1のチャンバの少なくとも一部および前記第2のチャンバの少なくとも一部は、前記第1の火工装薬と前記第2の火工装薬との間のバリアを形成する、請求項1から9の何れか1項に記載の着用可能なマルチショット注射パッチ。 - 前記基部が、前記マスク層と前記第1の容器および前記第2の容器の双方との間に配置されたシートを更に備え、
前記シートが、前記第1のチャンバを覆うように配置された第1のダイヤフラムと、前記第2のチャンバを覆うように配置された第2のダイヤフラムを有する、請求項10に記載の装着可能なマルチショット注射パッチ。 - 前記第1のダイヤフラムおよび前記第2のダイヤフラムのそれぞれは、ドーム形状を有する、請求項11に記載の装着可能なマルチショット注射パッチ。
- 前記第1の容器および前記第2の容器の各々が球形状を有する、請求項12に記載の着用可能なマルチショット注射パッチ。
- 前記1つまたは複数の電子部品が前記第1の火工装薬を起爆するとき、前記第1の火工装薬が圧力スパイクを引き起こして前記第1のダイヤフラムを前記第1の容器に向かって移動させ、前記第1の容器から前記第1の薬剤の少なくとも一部を噴出するように前記第1のダイヤフラムが柔軟であり、
前記1つまたは複数の電子部品が前記第2の火工装薬を起爆するとき、前記第2の火工装薬が圧力スパイクを引き起こして前記第2のダイヤフラムを前記第2の容器に向かって移動させ、前記第2の容器から前記第2の薬剤の少なくとも一部を噴出するように前記第2のダイヤフラムが柔軟である、
請求項11から13の何れか1項に記載の着用可能なマルチショット注射パッチ。 - 前記基部がクランプシートを更に備え、前記第1の容器および前記第2の容器が前記クランプシート内に配置される、請求項1から14の何れか1項に複数の着用可能なマルチショット注射パッチ。
- 着用可能なマルチショット注射パッチを製造する方法であって、
底面および上面を有し、且つ、前記底面と前記上面との間に配置された複数の容器を備え、前記底面が患者の皮膚に対して配置されるように構成され、前記複数の容器における各々が薬剤を収容する、第1の部品組立品を提供することと、
複数のチャンバを備え、前記複数のチャンバの各々が火工装薬を有する第2の部品組立品を提供することと、
前記複数のチャンバが前記底面からみて前記複数の容器の反対側に配置されるように、前記第2の部品組立品を前記第1の部品組立品における前記上面に接合することと、
を含む、マルチショット注射パッチの製造方法。 - 前記複数のチャンバは、少なくとも前記第2の部品組立品が前記第1の部品組立品に接合されるときに、前記複数の容器と整列される、請求項16に記載のマルチショット注射パッチの製造方法。
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20881002.8A EP4052744A4 (en) | 2019-10-30 | 2020-10-29 | MULTI-INJECTION PATCH |
CN202080076376.4A CN114616023A (zh) | 2019-10-30 | 2020-10-29 | 多点注射贴片 |
US17/771,948 US20230001082A1 (en) | 2019-10-30 | 2020-10-29 | Multi-shot injection patch |
JP2021553699A JPWO2021085565A1 (ja) | 2019-10-30 | 2020-10-29 | |
KR1020227017583A KR20220091520A (ko) | 2019-10-30 | 2020-10-29 | 멀티 샷 주사 패치 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962928266P | 2019-10-30 | 2019-10-30 | |
US62/928,266 | 2019-10-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021085565A1 true WO2021085565A1 (ja) | 2021-05-06 |
Family
ID=75715197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2020/040706 WO2021085565A1 (ja) | 2019-10-30 | 2020-10-29 | マルチショット注射パッチ |
Country Status (6)
Country | Link |
---|---|
US (1) | US20230001082A1 (ja) |
EP (1) | EP4052744A4 (ja) |
JP (1) | JPWO2021085565A1 (ja) |
KR (1) | KR20220091520A (ja) |
CN (1) | CN114616023A (ja) |
WO (1) | WO2021085565A1 (ja) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5860957A (en) * | 1997-02-07 | 1999-01-19 | Sarcos, Inc. | Multipathway electronically-controlled drug delivery system |
US20060216337A1 (en) * | 2005-03-28 | 2006-09-28 | Van Laar Kurt D | Needeleless medication delivery system |
JP2006524120A (ja) * | 2003-04-21 | 2006-10-26 | ストラテージェント ライフ サイエンシズ | マイクロジェットで反復的に薬物を搬送する装置および方法 |
JP2010504797A (ja) * | 2006-09-29 | 2010-02-18 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 複数ノズル経皮ドラッグデリバリー(drugdelivery)システム |
JP2016049246A (ja) | 2014-08-29 | 2016-04-11 | 株式会社ダイセル | 無針注射器 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3308818A (en) * | 1964-07-24 | 1967-03-14 | Eugene V Rutkowski | Injection cartridge |
DE19701494A1 (de) * | 1997-01-17 | 1998-07-23 | Boehringer Mannheim Gmbh | Transdermales Injektionssystem |
TWI222370B (en) * | 2001-12-14 | 2004-10-21 | Roche Diagnostics Gmbh | Needleless hypodermic injection device |
-
2020
- 2020-10-29 JP JP2021553699A patent/JPWO2021085565A1/ja active Pending
- 2020-10-29 CN CN202080076376.4A patent/CN114616023A/zh active Pending
- 2020-10-29 EP EP20881002.8A patent/EP4052744A4/en active Pending
- 2020-10-29 WO PCT/JP2020/040706 patent/WO2021085565A1/ja active Application Filing
- 2020-10-29 US US17/771,948 patent/US20230001082A1/en active Pending
- 2020-10-29 KR KR1020227017583A patent/KR20220091520A/ko unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5860957A (en) * | 1997-02-07 | 1999-01-19 | Sarcos, Inc. | Multipathway electronically-controlled drug delivery system |
JP2006524120A (ja) * | 2003-04-21 | 2006-10-26 | ストラテージェント ライフ サイエンシズ | マイクロジェットで反復的に薬物を搬送する装置および方法 |
US20060216337A1 (en) * | 2005-03-28 | 2006-09-28 | Van Laar Kurt D | Needeleless medication delivery system |
JP2010504797A (ja) * | 2006-09-29 | 2010-02-18 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 複数ノズル経皮ドラッグデリバリー(drugdelivery)システム |
JP2016049246A (ja) | 2014-08-29 | 2016-04-11 | 株式会社ダイセル | 無針注射器 |
Non-Patent Citations (1)
Title |
---|
See also references of EP4052744A4 |
Also Published As
Publication number | Publication date |
---|---|
EP4052744A4 (en) | 2023-11-29 |
CN114616023A (zh) | 2022-06-10 |
JPWO2021085565A1 (ja) | 2021-05-06 |
US20230001082A1 (en) | 2023-01-05 |
EP4052744A1 (en) | 2022-09-07 |
KR20220091520A (ko) | 2022-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1205456C (zh) | 防御装置,尤其是自卫装置和可用在该装置内的存储单元 | |
JP2005511254A (ja) | 無針の皮下注射装置 | |
JPH01227764A (ja) | 生きた細胞及び組織内へ物質を分配する分配装置 | |
JPH068159A (ja) | 発射薬用帯 | |
JP6937590B2 (ja) | ハイブリッドインフレータ、かかるハイブリッドインフレータを備えるエアバッグユニット及び車両の安全システム、並びに衝撃波を形成する方法 | |
CA2671374A1 (en) | Controlling transient pressure conditions in a wellbore | |
US20050103925A1 (en) | Projectile diverter | |
WO2021085565A1 (ja) | マルチショット注射パッチ | |
WO2001069164A1 (en) | Improved projectile diverter | |
US7455655B2 (en) | Needleless injection device comprising means for regulating the gas pressure level in the combustion chamber | |
US9371801B2 (en) | Ignition device for two-pulse rocket motor with thermal barrier membrane | |
JP7034076B2 (ja) | 投与装置 | |
US10549038B2 (en) | Syringe | |
KR20170028940A (ko) | 이중 멤브레인을 가진 바늘 없는 주입 장치 | |
CA2932666C (en) | Device for a special effect explosion or burst | |
CN102047068B (zh) | 管座装置 | |
RU2357181C1 (ru) | Газодинамический источник давления | |
WO2021085564A1 (ja) | 遺伝子銃 | |
RU2347931C1 (ru) | Двухрежимный ракетный двигатель твердого топлива | |
CN108426490A (zh) | 一种环保可燃气体鞭炮 | |
CN114306916B (zh) | 基于冲击波微射流体表无创快速给药柔性微***及其方法 | |
WO2021246061A1 (ja) | 無針注射器 | |
CN214470411U (zh) | 一种定向引爆喷发的礼宾花 | |
WO2022004334A1 (ja) | 無針注射器 | |
RU2617822C2 (ru) | Пневматическая мина нелетального действия |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20881002 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2021553699 Country of ref document: JP |
|
ENP | Entry into the national phase |
Ref document number: 20227017583 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2020881002 Country of ref document: EP Effective date: 20220530 |